Log in automatically

Log in | New user?


St. Jude Medical Announces FDA And European CE Mark Approvals Of The IsoFlex Optim Pacing Lead
                   
medicalnewstoday.com     May 16, 2008            

St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of the IsoFlex® Optim™ pacing lead. The small-diameter lead is built on the proven IsoFlex® pacing lead platform, and features the company's exclusive Optim® insulation material....


Full Coverage:

                   

St. Jude says its wires have low problem rate

startribune.com     May 16, 2008          

St. Jude Medical Inc. said Thursday that data from four studies tracking performance of "Riata"-brand heart-defibrillator wires in thousands of patients show very low rates of serious problems, including fractures and perforations. Problems with defibrillator leads, or wires that connect the...

analysis/comments

St. Jude wins FDA approval for heart surgery tools

finanznachrichten.de     May 15, 2008          

ST. PAUL, Minn. (AP) - Medical device maker St. Jude Medical Inc. said Thursday the Food and Drug Administration and European regulators approved the use of delivery tools for placing cardiac pacing leads in difficult to reach sections of the heart. St. Jude's CPS Duo stylet and guidewire system...

analysis/comments

St. Jude gets FDA approval for pacemaker component

finanznachrichten.de     May 13, 2008          

ST. PAUL, Minn. (AP) - Medical device maker St. Jude Medical Inc. said Tuesday the Food and Drug Administration and European regulators approved a new component for the company's pacemakers and implantable heart devices. The IsoFlex Optim pacing lead connects heart tissue to the pacing device....

analysis/comments

St. Jude gets FDA approval for pacemaker component

ibtimes.com     May 13, 2008          

ST. PAUL, Minn. (AP) - Medical device maker St. Jude Medical Inc. said Tuesday the Food and Drug Administration and European regulators approved a new component for the company's pacemakers and implantable heart devices. The IsoFlex Optim pacing lead connects heart tissue to the pacing device....

analysis/comments

                   

St. Jude Medical Announces FDA and European CE Mark Approvals of the IsoFlex Optim Pacing Lead

wallstreet-online.de     May 13, 2008          

St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of the IsoFlex(R) Optim(TM) pacing lead. The small-diameter lead is built on the proven IsoFlex(R) pacing lead platform, and features the company´s exclusive Optim(R)...

analysis/comments